Irska - engleski - HPRA (Health Products Regulatory Authority)

takeda gmbh - pantoprazole sodium sesquihydrate - tablets gastro-resistant - 40 milligram

Irska - engleski - HPRA (Health Products Regulatory Authority)

takeda gmbh - pantoprazole sodium sesquihydrate - tablets gastro-resistant - 20 milligram

Irska - engleski - HPRA (Health Products Regulatory Authority)

takeda gmbh - pantoprazole sodium hydrate - pdr for soln for injection - 40 milligram

Irska - engleski - HPRA (Health Products Regulatory Authority)

takeda uk limited - pantoprazole sodium hydrate - pdr for soln for injection - 40 milligram - proton pump inhibitors

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

takeda uk ltd - pantoprazole sodium sesquihydrate - powder for solution for injection - 40mg

Irska - engleski - HPRA (Health Products Regulatory Authority)

takeda products ireland ltd - pantoprazole sodium sesquihydrate - powder for solution for injection - 40 milligram(s) - proton pump inhibitors; pantoprazole

Australija - engleski - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir disoproxil fumarate; rilpivirine hydrochloride; emtricitabine -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

tri-med distributors pty ltd - urea (14c); urea [14c] -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

tri-med distributors pty ltd - urea (14c) -

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - emtricitabine 200mg;  ;  ;  ; rilpivirine hydrochloride 27.5mg equivalent to rilpivirine free base 25 mg;  ; tenofovir disoproxil fumarate 300mg;  ;  ;   - film coated tablet - active: emtricitabine 200mg       rilpivirine hydrochloride 27.5mg equivalent to rilpivirine free base 25 mg   tenofovir disoproxil fumarate 300mg       excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry polysorbate 20 povidone pregelatinised maize starch purified water - eviplera is indicated for the treatment of hiv infection in treatment-na?ve adult patients with plasma hiv-1 rna less than or equal to 100,000 copies/ml at the start of therapy. eviplera is also indicated in certain virologically-suppressed (hiv-1 rna <50 copies/ml) adult patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see clinical trials). patients must not have a history of resistance to any of the components of eviplera (tenofovir df, emtricitabine or rilpivirine).